Literature DB >> 31427441

STAT3 Targets ERR-α to Promote Epithelial-Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells.

Jia-Hui Ma1, Jie Qi2, Shi-Qi Lin1, Cai-Yun Zhang1, Fang-Yuan Liu1, Wei-Dong Xie1, Xia Li3,2,4.   

Abstract

STAT3 is constitutively activated in many malignant tumor types and plays an important role in multiple aspects of cancer aggressiveness. In this study, we found that estrogen-related receptor α (ERR-α) correlating with STAT3 was highly expressed in triple-negative breast cancer (TNBC) cell lines and tissues, which was associated with both the pathologic stage and prognosis of patients with TNBC. In vitro studies showed that ERR-α promoted TNBC cell migration and invasion, which was regulated by STAT3. Phosphorylated STAT3 (p-STAT3, Tyr 705) could bind to the promotor of ERR-α, and activate its transcription, which was suggested by luciferase assay and chromatin immunoprecipitation assay. We also found that ERR-α was the key target gene regulated by STAT3 in promoting epithelial-mesenchymal transition (EMT), migration, and invasion. ERR-α upregulated the expression of ZEB1, N-cadherin, and vimentin while downregulated the expression of E-cadherin. Furthermore, in vivo studies showed that ERR-α could increase the metastasis ability of TNBC. Our finding demonstrated that ERR-α was a direct regulatory gene target of p-STAT3, which was enriched for processes involving invasion and metastasis in TNBC and provided insight into TNBC pathogenesis, as well as a potential therapeutic option against TNBC metastasis. IMPLICATIONS: Our research first showed that p-STAT3 (Tyr 705) could bind to the promotor region of ERR-α and promote EMT in TNBC by ZEB1 pathways, thus providing a potential clinical target for TNBC. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31427441     DOI: 10.1158/1541-7786.MCR-18-1194

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

Review 1.  Estrogen-related receptor alpha in select host functions and cancer: new frontiers.

Authors:  Harmit S Ranhotra
Journal:  Mol Cell Biochem       Date:  2022-02-09       Impact factor: 3.396

Review 2.  Role of HIF-1α/ERRα in Enhancing Cancer Cell Metabolism and Promoting Resistance of Endometrial Cancer Cells to Pyroptosis.

Authors:  Pingping Su; Lirui Yu; Xiaodan Mao; Pengming Sun
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

3.  DNA minicircles as novel STAT3 decoy oligodeoxynucleotides endowed with anticancer activity in triple-negative breast cancer.

Authors:  Geoffrey Casas; Federico Perche; Patrick Midoux; Chantal Pichon; Jean-Marc Malinge
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-22       Impact factor: 10.183

4.  KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer.

Authors:  Mei Zhou; Prabhakar Pitta Venkata; Suryavathi Viswanadhapalli; Bridgitte Palacios; Salvador Alejo; Yihong Chen; Yi He; Uday P Pratap; Junhao Liu; Yi Zou; Zhao Lai; Takayoshi Suzuki; Andrew J Brenner; Rajeshwar R Tekmal; Ratna K Vadlamudi; Gangadhara R Sareddy
Journal:  Breast Cancer Res Treat       Date:  2020-10-14       Impact factor: 4.872

5.  FGFR2/STAT3 Signaling Pathway Involves in the Development of MMTV-Related Spontaneous Breast Cancer in TA2 Mice.

Authors:  Jiaxing Du; Qi Zhao; Kai Liu; Zugui Li; Fangmei Fu; Kexin Zhang; Hao Zhang; Minying Zheng; Yongjie Zhao; Shiwu Zhang
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

Review 6.  Balancing STAT Activity as a Therapeutic Strategy.

Authors:  Kelsey L Polak; Noah M Chernosky; Jacob M Smigiel; Ilaria Tamagno; Mark W Jackson
Journal:  Cancers (Basel)       Date:  2019-11-03       Impact factor: 6.575

Review 7.  Role of STAT3 signaling pathway in breast cancer.

Authors:  Jia-Hui Ma; Li Qin; Xia Li
Journal:  Cell Commun Signal       Date:  2020-02-28       Impact factor: 5.712

8.  Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.

Authors:  Martina Milani; Eleonora Mammarella; Simona Rossi; Chiara Miele; Serena Lattante; Mario Sabatelli; Mauro Cozzolino; Nadia D'Ambrosi; Savina Apolloni
Journal:  J Neuroinflammation       Date:  2021-06-12       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.